Literature DB >> 19700240

Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562.

Kin Tak Chan1, Kwan Li, Shiu Lam Liu, Kee Hung Chu, Melvin Toh, Wei Dong Xie.   

Abstract

Cucurbitacin B is a natural anti-cancer compound found in Cucurbitaceae. Although the anti-cancer activity of cucurbitacin B in human leukemia cells has been reported, the underlining mechanism is still unclear. To clarify its anti-cancer activity and the mechanism of action, five different leukemia cell lines (CCRF-CEM, K562, MOLT-4, RPMI-8226 and SR) of the National Cancer Institute panel were treated with cucurbitacin B. Leukemia cell growth was inhibited by cucurbitacin B with GI(50) ranged from 15.6 nM to 35.3 nM and the growth inhibition effect was attributable to G2/M phase arrest and apoptosis. Western blotting analysis of cell signaling molecules indicated that cucurbitacin B inhibits STAT3 activation and the Raf/MEK/ERK pathway in the K562 cells. Crown Copyright 2009. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19700240     DOI: 10.1016/j.canlet.2009.07.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  31 in total

1.  Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network.

Authors:  Anne Trécul; Franck Morceau; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2012-01-25       Impact factor: 5.523

2.  Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.

Authors:  Dhong Hyun Lee; Nils H Thoennissen; Catherine Goff; Gabriela B Iwanski; Charles Forscher; Ngan B Doan; Jonathan W Said; H Phillip Koeffler
Journal:  Cancer Lett       Date:  2011-03-26       Impact factor: 8.679

3.  Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.

Authors:  Yener Kurman; Ilker Kiliccioglu; Asiye U Dikmen; Guldal Esendagli; Cenk Y Bilen; Sinan Sozen; Ece Konac
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-06

4.  Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.

Authors:  Sumana Dakeng; Suwit Duangmano; Weena Jiratchariyakul; Yaowalak U-Pratya; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

5.  The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer.

Authors:  Ahmed Aribi; Sigal Gery; Dhong Hyun Lee; Nils H Thoennissen; Gabriela B Thoennissen; Rocio Alvarez; Quoc Ho; Kunik Lee; Ngan B Doan; Kin T Chan; Melvin Toh; Jonathan W Said; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2012-12-13       Impact factor: 7.396

6.  Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.

Authors:  Weikai Chen; Amanda Leiter; Dong Yin; Muriel Meiring; Vernon J Louw; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2010-09       Impact factor: 5.650

7.  Cucurbitacin E exhibits anti-inflammatory effect in RAW 264.7 cells via suppression of NF-κB nuclear translocation.

Authors:  Jing Qiao; Li-hui Xu; Jian He; Dong-yun Ouyang; Xian-hui He
Journal:  Inflamm Res       Date:  2013-01-30       Impact factor: 4.575

8.  Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.

Authors:  Fardous F El-Senduny; Farid A Badria; Ahmed M El-Waseef; Subhash C Chauhan; Fathi Halaweish
Journal:  Tumour Biol       Date:  2015-08-05

9.  The effects of methanolic, chloroform, and ethylacetate extracts of the Cucurbita pepo L. on the delay type hypersensitivity and antibody production.

Authors:  A Jafarian; B Zolfaghari; M Parnianifard
Journal:  Res Pharm Sci       Date:  2012-10

10.  The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.

Authors:  Moltira Promkan; Sumana Dakeng; Subhas Chakrabarty; Oliver Bögler; Pimpicha Patmasiriwat
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.